Published in Endokrynol Pol on December 30, 2009
Ussefulnes of imaging techniques in the diagnostics of precocious puberty in boys. Pol J Radiol (2011) 0.75
Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep (2010) 1.56
Ezetimibe--a new approach in hypercholesterolemia management. Pharmacol Rep (2011) 1.47
Transforming growth factor β1 (TGFβ1) in physiology and pathology. Endokrynol Pol (2013) 1.10
Vascular endothelial growth factor (VEGF) - part 1: in physiology and pathophysiology. Endokrynol Pol (2011) 1.09
Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy. Clin Exp Med (2009) 1.05
[Autoimmune polyglandular syndrome type 2 in pregnancy: a case report]. Przegl Lek (2013) 0.97
Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism (2005) 0.93
AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) increases the production of toxic molecules and affects the profile of cytokines release in LPS-stimulated rat primary microglial cultures. Neurotoxicology (2009) 0.92
Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.92
Growth hormone therapy in children and adults. Pharmacol Rep (2007) 0.91
Effect of atorvastatin and fenofibric acid on adipokine release from visceral and subcutaneous adipose tissue of patients with mixed dyslipidemia and normolipidemic subjects. Pharmacol Rep (2010) 0.89
Vascular endothelial growth factor (VEGF) - part 2: in endocrinology and oncology. Endokrynol Pol (2011) 0.89
Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy. Clin Exp Med (2008) 0.88
Incretin-based therapies in the treatment of type 2 diabetes--more than meets the eye? Eur J Intern Med (2013) 0.86
Ambivalent effects of compound C (dorsomorphin) on inflammatory response in LPS-stimulated rat primary microglial cultures. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.86
Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension. Pharmacol Rep (2005) 0.85
Pleiotropic effects of angiotensin-converting enzyme inhibitors in normotensive patients with coronary artery disease. Pharmacol Rep (2008) 0.85
A successful case of pain management using metformin in a patient with adiposis dolorosa. Int J Clin Pharmacol Ther (2013) 0.83
The relationship between the daily profile of chosen biochemical markers of bone metabolism and melatonin and other hormone secretion in rats under physiological conditions. Neuro Endocrinol Lett (2002) 0.82
Unfavorable effects of hyperprolactinemia in autoimmune endocrine disorders. Neuro Endocrinol Lett (2012) 0.82
The dawn phenomenon and the Somogyi effect - two phenomena of morning hyperglycaemia. Endokrynol Pol (2011) 0.82
[Unique case of caecum plasmablastic lymphoma CD138(+) in patient with late diagnosed colon neuroendocrine carcinoma]. Endokrynol Pol (2006) 0.81
[Tear film profile in patients with active thyroid orbithopathy]. Klin Oczna (2005) 0.81
Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.81
The influence of pinealectomy and melatonin administration on the dynamic pattern of biochemical markers of bone metabolism in experimental osteoporosis in the rat. Neuro Endocrinol Lett (2002) 0.80
Update on the management of polycystic ovary syndrome. Pharmacol Rep (2006) 0.80
Eplerenone promotes alternative activation in human monocyte-derived macrophages. Pharmacol Rep (2013) 0.80
Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C. World J Gastroenterol (2006) 0.80
The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after the menopause. Endokrynol Pol (2006) 0.80
Serum free testosterone in men with coronary artery atherosclerosis. Med Sci Monit (2003) 0.80
[Diagnostic difficulties in diagnosis of splenic abscesses]. Wiad Lek (2007) 0.79
Lymphocyte-suppressing, endothelial-protective and systemic anti-inflammatory effects of metformin in fenofibrate-treated patients with impaired glucose tolerance. Pharmacol Rep (2013) 0.79
Controlling newly diagnosed type 2 diabetes mellitus with metformin managed pain symptoms in a patient affected with Dercum's disease. Pain Med (2012) 0.79
Serum concentrations of leptin, adiponectin, and interleukin-6 in postmenopausal women with Hashimoto's thyroiditis. Endokrynol Pol (2010) 0.79
[Is every case of muscle damage during hypolipemic therapy the side effect of this therapy? A case report]. Pol Arch Med Wewn (2007) 0.79
Lymphocyte-suppressing action of angiotensin-converting enzyme inhibitors in coronary artery disease patients with normal blood pressure. Pharmacol Rep (2011) 0.79
Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly? Neuro Endocrinol Lett (2008) 0.79
[Atypical pituitary tumors]. Pol Merkur Lekarski (2012) 0.79
The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours. Endokrynol Pol (2012) 0.79
[Incidentaloma--one of the greatest challenges of modern endocrinology]. Pol Merkur Lekarski (2006) 0.79
Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures. Pharmacol Rep (2010) 0.79
Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance. Pharmacol Rep (2013) 0.78
[Designing and optimization of real-time RT-PCR technique for the detection of hepatitis C virus (HCV) genome in blood serum as internal laboratory quality control]. Przegl Epidemiol (2011) 0.78
Monocyte-suppressing effect of high-dose metformin in fenofibrate-treated patients with impaired glucose tolerance. Pharmacol Rep (2013) 0.78
Anti-inflammatory and monocyte-suppressing effects of simvastatin in patients with impaired fasting glucose. Basic Clin Pharmacol Toxicol (2010) 0.78
Role of the SOCS in monocytes/macrophages-related pathologies. Are we getting closer to a new pharmacological target? Pharmacol Rep (2012) 0.78
[Central precocious puberty]. Endokrynol Pol (2009) 0.78
Eplerenone mimics features of the alternative activation in macrophages obtained from patients with heart failure and healthy volunteers. Eur J Pharmacol (2014) 0.78
Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6. Endokrynol Pol (2015) 0.78
The effect of perindopril and enalapril on plasma resistin levels in normotensive patients with coronary heart disease. Endokrynol Pol (2010) 0.78
SOCS and diabetes--ups and downs of a turbulent relationship. Cell Biochem Funct (2013) 0.78
[Lipodystrophy: a new insight into an old disease]. Przegl Lek (2012) 0.77
[The role of TLR4 receptor in development of inflammation and carcinogenesis in ulcerative colitis and pharmacotherapy of this disorder]. Wiad Lek (2013) 0.77
CGRP plasma level changes in patients with temporomandibular disorders treated with occlusal splints - a randomised clinical trial. Endokrynol Pol (2014) 0.77
Atorvastatin and fenofibric acid differentially affect the release of adipokines in the visceral and subcutaneous cultures of adipocytes that were obtained from patients with and without mixed dyslipidemia. Pharmacol Rep (2011) 0.77
[Subclinical hyperthyroidism]. Endokrynol Pol (2008) 0.77
Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels. Neuro Endocrinol Lett (2006) 0.77
A comparison of the levels of hepatocyte growth factor in serum in patients with type 1 diabetes mellitus with different stages of diabetic retinopathy. Endokrynol Pol (2008) 0.77
[Primary hyperparathyroidism]. Pol Arch Med Wewn (2005) 0.77
Adiponectin, leptin, resistin and insulin blood concentrations in patients with ischaemic cerebral stroke. Endokrynol Pol (2012) 0.77
Effects of bisoprolol and cilazapril on the central retinal artery blood flow in patients with essential hypertension--preliminary results. Ups J Med Sci (2010) 0.77
Acute phase proteins: C-reactive protein and fibrinogen in young women with polycystic ovary syndrome. Pathophysiology (2006) 0.77
[Subclinical hypothyroidism]. Wiad Lek (2008) 0.77
Acromegaly--a novel view of the patient. Polish proposals for diagnostic and therapeutic procedures in the light of recent reports. Endokrynol Pol (2014) 0.77
[Vascular endothelial growth factor (VEGF) in endocrinology and oncology]. Endokrynol Pol (2011) 0.77
[Sex hormones and adipocytokines in postmenopausal women]. Pol Merkur Lekarski (2006) 0.77
The effect of angiotensin-converting enzyme inhibitors on plasma adipokine levels in normotensive patients with coronary artery disease. Endokrynol Pol (2010) 0.76
Short-term antihypertensive therapy lowers the C-reactive protein level. Postepy Hig Med Dosw (Online) (2012) 0.76
[Atypical clinical presentation of autoimmune polyglandular syndrome type 4]. Przegl Lek (2011) 0.76
The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia. Fundam Clin Pharmacol (2011) 0.76
Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances. Pharmacol Rep (2010) 0.76
[The role of the oxidative mechanisms in the pathogenesis of age related macular degeneration]. Klin Oczna (2005) 0.76
The effect of short-term combined treatment with simvastatin and ezetimibe on circulating adipokine levels in patients with isolated hypercholesterolemia. Endokrynol Pol (2014) 0.76
[Adipose tissue: a new endocrine organ]. Przegl Lek (2005) 0.76
Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. Postepy Hig Med Dosw (Online) (2011) 0.76
Octreotide suppression test in diagnosing and predicting the outcome of therapy in patients with neuroendocrine tumors. Preliminary report. Endokrynol Pol (2007) 0.76
[The apolipoprotein E polymorphism in age related macular degeneration]. Klin Oczna (2004) 0.76
[Adrenal insufficiency]. Wiad Lek (2012) 0.76
Wernicke-Korsakoff syndrome in the course of thyrotoxicosis - a case report. Endokrynol Pol (2011) 0.76
Polypeptide growth factors in gastroenteropancreatic neuroendocrine tumours. Endokrynol Pol (2007) 0.76
Hormonal supplementation in endocrine dysfunction in critically ill patients. Pharmacol Rep (2007) 0.76
Circadian rhythm of melatonin in postmenopausal asthmatic women with hormone replacement therapy. Neuro Endocrinol Lett (2002) 0.76
Transforming growth factor β1 (TGFβ1) and vascular endothelial growth factor (VEGF) in the blood of healthy people and patients with Graves' orbitopathy--a new mechanism of glucocorticoids action? Endokrynol Pol (2014) 0.76
Circadian rhythm of melatonin in patients with colorectal carcinoma. Neuro Endocrinol Lett (2002) 0.76
Mixed germ cells tumour primarily located in the thyroid -- a case report. Endokrynol Pol (2012) 0.76
A Novel, Highly Selective RT-QPCR Method for Quantification of MSRV Using PNA Clamping Syncytin-1 (ERVWE1). Mol Biotechnol (2015) 0.76
The influence of ezetimibe on classical and alternative activation pathways of monocytes/macrophages isolated from patients with hypercholesterolemia. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.75
[Serum adiponectin levels in patients with acromegaly]. Pol Merkur Lekarski (2005) 0.75
[Dry eye syndrom--multispecialistic disease. Part two: diagnostic procedure and treatment]. Wiad Lek (2011) 0.75
Postpartum hypothalamic dysfunction--a case report. Endokrynol Pol (2010) 0.75
[Glucocorticoid-induced osteoporosis]. Endokrynol Pol (2007) 0.75
[Selected endocrine abnormalities in eating disorders]. Wiad Lek (2010) 0.75
[Dry eye syndrome--multispecialistic disease. Part one: Pathogenesis, signs, classification]. Wiad Lek (2010) 0.75